Carbon footprint and associated costs of asthma exacerbation care among UK adults

References

• Global Initiative for Asthma. Global strategy for asthma management and prevention, 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf. Accessed Sep 24 2021.
   Google Scholar
• Mukherjee M, Stoddart A, Gupta RP, et al. The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases. BMC Med. 2016;14(1):113.
   PubMedGoogle Scholar
• Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3:1.
   PubMedGoogle Scholar
• Lloyd A, Price D, Brown R. The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK. Prim Care Respir J. 2007;16(1):22–27.
   PubMedGoogle Scholar
• Ivanova JI, Bergman R, Birnbaum HG, et al. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Aller Clin Immunol. 2012;129(5):1229–1235.
   PubMed Web of Science ®Google Scholar
• Kim SH, Kim TW, Kwon J-W, et al. Economic costs for adult asthmatics according to severity and control status in Korean tertiary hospitals. J Asthma. 2012;49(3):303–309.
   Google Scholar
• Suruki RY, Daugherty JB, Boudiaf N, et al. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC Pulm Med. 2017;17(1):74.
   PubMed Web of Science ®Google Scholar
• Wilkinson AJ, Braggins R, Steinbach I, et al. Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England. BMJ Open. 2019;9(10):e028763.
   PubMed Web of Science ®Google Scholar
• Janson C, Henderson R, Löfdahl M, et al. Carbon footprint impact of the choice of inhalers for asthma and COPD. Thorax. 2020;75(1):82–84.
   PubMed Web of Science ®Google Scholar
• Lavorini F, Corrigan CJ, Barnes PJ, Aerosol Drug Management Improvement Team, et al. Retail sales of inhalation devices in European countries: so much for a global policy. Respir Med. 2011;105(7):1099–1103.
   PubMed Web of Science ®Google Scholar
• Wilkinson AJK, Anderson G. Sustainability in inhaled drug delivery. Pharmaceut Med. 2020;34(3):191–199.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence. Patient decision aid: inhalers for asthma, 2020. Available from: https://www.nice.org.uk/guidance/ng80/resources/inhalers-for-asthma-patient-decision-aid-pdf-6727144573. Accessed Sep 24 2021.
   Google Scholar
• Sustainable Development Unit. Carbon hotspot: reducing inhalers. 2018. Available from: https://slideplayer.com/slide/16621227/. Accessed Sep 7 2021.
   Google Scholar
• Reddel HK, Taylor DR, Bateman ED, American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations, et al. An official American thoracic society/European respiratory society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009;180(1):59–99.
   PubMed Web of Science ®Google Scholar
• Department of Business E, & Industrial Strategy. Valuation of energy use and greenhouse gas. Supplementary guidance to the HM Treasury Green Book on Appraisal and Evaluation in Central Government 2019. Available from: https://www.gov.uk/government/publications/valuation-of-energy-use-and-greenhouse-gas-emissions-for-appraisal. Accessed Sep 24 2021.
   Google Scholar
• Office for National Statistics. Consumer pice inflation tables. 2021.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Asthma: diagnosis, monitoring and chronic management 2017. Available from: https://www.nice.org.uk/guidance/ng80. Accessed Sep 24 2021.
   Google Scholar
• British Thoracic Society/Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma—A national clinical guideline 2019. Available from: https://www.sign.ac.uk/media/1773/sign158-updated.pdf. Accessed Sep 24 2021.
   Google Scholar
• Maselli DJ, Peters JI. Medication regimens for managing acute asthma. Respir Care. 2018;63(6):783–796.
   PubMed Web of Science ®Google Scholar
• Tennison I, Roschnik S, Ashby B, et al. Health care's response to climate change: a carbon footprint assessment of the NHS in England. Lancet Planet Health. 2021;5(2):e84–e92.
   PubMedGoogle Scholar
• Bloom CI, Nissen F, Douglas IJ, et al. Exacerbation risk and characterisation of the UK's asthma population from infants to old age. Thorax. 2018;73(4):313–320.
   PubMed Web of Science ®Google Scholar
• Jones TL, Owen J, Elliott S, et al. Physiological and biological predictors of length of stay and recovery in adults with acute asthma: an observational cohort study. Clin Respir J. 2018;12(1):200–206.
   PubMed Web of Science ®Google Scholar
• Asthma facts and statistics: Asthma UK. Available from: https://www.asthma.org.uk/about/media/facts-and-statistics/. Accessed Aug 18 2021.
   Google Scholar
• Kuna P, Peters MJ, Manjra AI, et al. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract. 2007;61(5):725–736.
   PubMed Web of Science ®Google Scholar
• Dennis SM, Sharp SJ, Vickers MR, et al. Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy working group of the national asthma task force and the MRC general practice research framework. Lancet. 2000;355(9216):1675–1679.
   PubMed Web of Science ®Google Scholar
• Charlesworth M, Swinton F. Anaesthetic gases, climate change, and sustainable practice. Lancet Planet Health. 2017;1(6):e216–e217.
   PubMedGoogle Scholar
• National Health Service (NHS) England. Childhood asthma. Last updated Mar 3 2022. Available from: https://www.england.nhs.uk/childhood-asthma/. Accessed Mar 7 2022.
   Google Scholar
• Gokhale M, Hattori T, Evitt L, et al. Burden of asthma exacerbations and health care utilization in pediatric patients with asthma in the US and England. Immun Inflamm Dis. 2020;8(2):236–245.
   PubMed Web of Science ®Google Scholar
• Ahrens RC. The role of the MDI and DPI in pediatric patients: children are not just miniature adults. Respir Care. 2005;50(10):1323–1328; discussion 1328–1330.
   PubMedGoogle Scholar
• Healthcare Without Harm. Health care’s climate footprint. 2019. Available from: https://noharm-global.org/sites/default/files/documents-files/5961/HealthCaresClimateFootprint_092319.pdf. Accessed Sep 30 2021.
   Google Scholar
• Sustainable Development Unit Archive: NHS England. Available from: https://www.england.nhs.uk/greenernhs/whats-already-happening/sustainable-development-unit-archive/. Accessed Aug 18 2021.
   Google Scholar
• National Health Society. Long term plan. 2019. Available from: https://www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term-plan-version-1.2.pdf. Accessed Sep 30 2021.
   Google Scholar
• Royal Pharmaceutical Society. RPS declaration of climate and ecological emergency 2021. Available from: https://www.rpharms.com/about-us/sustainability/declaration. Accessed Sep 24 2021.
   Google Scholar